Clinical Report: Evaluating the Diagnostic Accuracy of Interleukin-27 and C-Reactive Protein for Neonatal Sepsis
Overview
This systematic review and meta-analysis evaluates the diagnostic accuracy of Interleukin-27 (IL-27) compared to C-reactive protein (CRP) for neonatal sepsis. Findings indicate that IL-27 has superior sensitivity and specificity, suggesting it may be a more reliable biomarker for early diagnosis.
Background
Neonatal sepsis is a significant cause of morbidity and mortality, particularly in preterm infants. Early and accurate diagnosis is crucial for timely intervention, yet current biomarkers often yield inconsistent results. This study addresses the need for reliable diagnostic tools in this vulnerable population.
Data Highlights
Biomarker
Pooled Sensitivity
Pooled Specificity
AUC
IL-27
0.82 (95% CI, 0.77–0.87)
0.85 (95% CI, 0.80–0.90)
0.92
CRP
0.73 (95% CI, 0.65–0.79)
0.76 (95% CI, 0.69–0.83)
0.84
Key Findings
IL-27 demonstrated a pooled sensitivity of 0.82, significantly higher than CRP's 0.73.
The pooled specificity of IL-27 was 0.85, compared to CRP's 0.76.
The area under the curve (AUC) for IL-27 was 0.92, indicating robust predictive value.
Five controlled studies involving 495 neonates were included, all with acceptable methodological quality.
IL-27 may assist in the early and accurate diagnosis of neonatal sepsis in clinical practice.
Clinical Implications
The findings suggest that IL-27 could be a valuable biomarker for clinicians in diagnosing neonatal sepsis, potentially leading to improved patient outcomes. However, further research is needed to standardize diagnostic thresholds and timing for IL-27 use in clinical settings.
Conclusion
IL-27 shows superior diagnostic accuracy compared to CRP for neonatal sepsis, highlighting its potential role as a reliable biomarker in clinical practice. Continued investigation is warranted to confirm these findings and establish clinical guidelines.
